Baseline characteristics and medication
| Atorvastatin treated group | Control group | |
|---|---|---|
| Data are mean (SD) or number. | ||
| There were no significant differences between the two groups. | ||
| ACE, angiotensin converting enzyme; HDL, high density lipoprotein; NYHA, New York Heart Association. | ||
| Number of patients | 17 | 18 |
| Age (years) | 63 (12.5) | 67 (9.9) |
| Body mass index (kg/m2) | 26.5 (3.3) | 27.1 (3.3) |
| Cholesterol (mmol/l) | 5.22 (0.58) | 4.96 (0.88) |
| Triglycerides (mmol/l) | 1.37 (0.35) | 1.37 (0.3) |
| HDL (mmol/l) | 0.76 (0.15) | 0.79 (0.19) |
| Ejection fraction (%) | 26.6 (3.1) | 27.9 (6.6) |
| NYHA class | 3.6 (0.4) | 3.3 (0.7) |
| Medication | ||
| ACE inhibitors | 17 | 18 |
| Diuretics | 17 | 18 |
| β Blockers | 6 | 7 |
| Aldosterone inhibitors | 7 | 7 |
| Amiodarone | 4 | 5 |